01 January 2005
Imatinib mesylate induced severe bone marrow aplasia in a patient with long duration of chronic myelogenous leukemia treated previously with busulphan and hydroxyurea
Tadeusz Robak, Krzysztof Jamroziak, Agnieszka Janus, Adam Hołub, Halina Urbańska-Ryś, Ewa Wawrzyniak, Dorota Kupnicka, Joanna Góra-TyborCase Rep Clin Pract Rev 2005; 6:332-336 :: ID: 440493
Abstract
Background: Myelosuppresion is a relatively common side effect of imatinib mesylate (IM) therapy of chronic myelogenous leukemia (CML), although sustained severe bone marrow aplasia has rarely been
reported.
Case Report: Here, we describe a 76-year-old woman with a 15-year history of CML treated formerly with
busulfan and hydroxyurea, who developed severe bone marrow aplasia following treatment with IM. The patient was started on IM at a dose of 300 mg daily, when her disease progressed to the accelerated phase. She responded well to treatment by entering the second chronic phase of CML. However, after six months of IM therapy she developed profound pancytopenia. The histopathological examination of bone marrow revealed total aplasia without any haematopoietic cells. Despite the interruption of IM, hematopoiesis did not regenerated. The patient needed
filgrastim treatment and became red blood cells and platelets transfusion dependent. Finally,
the patient recovered from pancytopenia, and actually she is in good general condition with
haematological parameters within normal range.
Conclusions: Based on this observation and other reports, we hypothesize that long duration of CML, advanced phase of the disease and previous treatment, especially with busulphan, may increase the risk of
severe bone marrow aplasia as adverse event of IM therapy.
Keywords: imatinib, chronic myelocytic leukemia, bone marrow aplasia
43
In Press
14 Mar 2024 : Case report
Potential Indicators of Intestinal Necrosis in Portal Venous Gas: A Case Report of an 82-Year-Old Woman on ...Am J Case Rep In Press; DOI: 10.12659/AJCR.942966
05 Mar 2024 : Case report
Simultaneous Transcatheter Closure of a Ventricular Septal Defect and Pulmonary Valvuloplasty: A Case ReportAm J Case Rep In Press; DOI: 10.12659/AJCR.942032
06 Mar 2024 : Case report
Successful Healing of Periapical Pathology with Partial Pulpotomy in a Mature Permanent Molar: A Case ReportAm J Case Rep In Press; DOI: 10.12659/AJCR.942937
12 Mar 2024 : Case report
Successful Treatment of Lithium-Induced Nephrogenic Diabetes Insipidus with Celecoxib: A Promising Therapeu...Am J Case Rep In Press; DOI: 10.12659/AJCR.943244
Most Viewed Current Articles
07 Mar 2024 : Case report
Neurocysticercosis Presenting as Migraine in the United StatesDOI :10.12659/AJCR.943133
Am J Case Rep 2024; 25:e943133
10 Jan 2022 : Case report
A Report on the First 7 Sequential Patients Treated Within the C-Reactive Protein Apheresis in COVID (CACOV...DOI :10.12659/AJCR.935263
Am J Case Rep 2022; 23:e935263
19 Jul 2022 : Case report
Atlantoaxial Subluxation Secondary to SARS-CoV-2 Infection: A Rare Orthopedic Complication from COVID-19DOI :10.12659/AJCR.936128
Am J Case Rep 2022; 23:e936128
23 Feb 2022 : Case report
Penile Necrosis Associated with Local Intravenous Injection of CocaineDOI :10.12659/AJCR.935250
Am J Case Rep 2022; 23:e935250